文献速递肿瘤 PET/CT放射性药物与辐射防护

核医学影像评估自身免疫、炎症及肿瘤性疾病中细胞因子产生的策略:临床前研究综述

Nuclear Imaging Strategies to Evaluate Cytokine Production in Autoimmune, Inflammatory, and Neoplastic Diseases: A Review of Current Preclinical Research.
PubMed 文献 · J Nucl Med · 2025-12-03

本综述讨论了用于靶向特定细胞因子的临床前核医学显像剂(如PET、SPECT),这些显像剂可在原位实时检测细胞因子结合,弥补传统方法在灵敏度、异质性和半衰期方面的不足,未来有望用于临床监测癌症及自身免疫和炎症性疾病的进展与治疗反应。

要点

  • 核医学显像可在原位实时检测细胞因子结合,优于传统检测方法。
  • 综述聚焦于靶向特定细胞因子的临床前核医学显像剂。
  • 这些显像剂未来可能用于监测疾病进展和治疗反应。

核心结论

  • 核医学显像(PET、SPECT)可在原位实时检测细胞因子结合,有望用于临床监测癌症及自身免疫和炎症性疾病的进展与治疗反应。

研究设计与样本

  • 综述类文章,检索范围未在原文中报告。

主要发现

  • 传统细胞因子检测方法灵敏度有限,难以解决细胞因子异质性和短生物半衰期问题。
  • 核医学显像可在原位实时检测细胞因子结合。
  • 综述讨论了最有前景的靶向特定细胞因子的临床前核医学显像剂。

临床怎么用

  • 这些显像剂可能最终用于临床监测癌症及自身免疫和炎症性疾病的疾病进展和治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cytokines are small proteins that directly regulate immune cell proliferation and signaling. An improved understanding of cytokine expression in specific microenvironments provides critical insights into essential physiologic and pathophysiologic responses to disease and infection. Standard methods used to detect and quantify cytokines are not fully suitable for this purpose, given their limited sensitivity and capacity to address cytokine heterogeneity and short biologic half-lives. In contrast, nuclear imaging modalities (e.g., PET, SPECT) can be used to detect cytokine binding in situ in real time. In this review, we discuss some of the most promising preclinical nuclear imaging agents that have been developed to target specific cytokines. These agents may ultimately be used in the clinical setting to monitor disease progression and responses to treatments for cancer and autoimmune and inflammatory diseases.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Deck A, Lane S, Liles A, et al. Nuclear Imaging Strategies to Evaluate Cytokine Production in Autoimmune, Inflammatory, and Neoplastic Diseases: A Review of Current Preclinical Research. J Nucl Med. 2025. PMID: 41130793. doi:10.2967/jnumed.125.270425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。